“To surpass these limitations, Macdonald and the Cynata team have developed a novel manufacturing platform, called Cymerus, that utilizes mesenchymoangioblasts derived from induced pluripotent stem cells.”
“Cynata team” takes all the glory, no credit to the actual inventors.
when another company gets approval, the “problem” won’t be a problem. And then what do you have??
Cynata in 10, page-199
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.010(5.13%) |
Mkt cap ! $37.01M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.5¢ | $480 | 2.343K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15128 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 43657 | 1 |
View Market Depth
| Last trade - 15.39pm 02/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |